Proterris
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Proterris Information
Geographic Data
Address:
City: Boston
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide. Proterris has prioritized CO development in delayed graft function (DGF), acute liver failure, and non-alcoholic steatohepatitis (NASH), with significant opportunities in a number of other indications, including but not limited to acute kidney injury (AKI), renal fibrosis, and idiopathic pulmonary fibrosis (IPF). It is headquartered in Boston, Massachusetts.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Venture Round | $2M | 12/2017 | Venture Round | 1 | - |
Portugal Ventures Portugal Ventures |
12/2017 | Venture Round | 1 | - |
Portugal Ventures Portugal Ventures |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 12/2017 | Alfama |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
